Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BY-NC-ND 4.0International Forum of Allergy & Rhinology

North American Delphi Consensus Study on Sinonasal Malignancy Survivorship Care

  • Matheus Sewastjanow‐Silva1
  • Samagra Jain2
  • Rita Snyder2
  • Erin L. McKean3
  • Ralph Abi Hachem4
  • Nithin D. Adappa5
  • J. Ken Byrd6
  • Ricardo L. Carrau7
  • Marc A. Cohen8
  • Ivan H. El‐Sayed9
  • Mathew N. Geltzeiler10
  • Ehab Y. Hanna1
7 more authors
  • Edward C. Kuan11
  • Nyall R. London12,13
  • Zoukaa B. Sargi14
  • Carl H. Snyderman15
  • Marilene B. Wang16
  • Ian J. Witterick17
  • Shirley Y. Su1
17 affiliations
  1. 1Department of Head and Neck Surgery The University of Texas MD Anderson Cancer Center Houston Texas USA
  2. 2Baylor College of Medicine Houston Texas USA
  3. 3Department of Otolaryngology‐Head and Neck Surgery University of Michigan Ann Arbor Michigan USA
  4. 4Department of Head and Neck Surgery & Communication Sciences Duke University Durham North Carolina USA
  5. 5Department of Otorhinolaryngology‐Head and Neck Surgery Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA
  6. 6Department of Otolarynology Head and Neck Surgery Augusta University Augusta Georgia USA
  7. 7Department of Otolaryngology‐Head and Neck Surgery The Ohio State University Columbus Ohio USA
  8. 8Department of Surgery Head and Neck Service Memorial Sloan Kettering Cancer Center New York New York USA
  9. 9Department of Otolaryngology‐Head and Neck Surgery University of California San Francisco California USA
  10. 10Department of Otolarynology Head and Neck Surgery Oregon Health & Science University Portland Oregon USA
  11. 11Departments of Otolaryngology‐Head and Neck Surgery and Neurological Surgery University of California Irvine Orange California USA
  12. 12Department of Otolaryngology‐Head and Neck Surgery Johns Hopkins University School of Medicine Baltimore Maryland USA
  13. 13Sinonasal and Skull Base Tumor Program Surgical Oncology Program Center For Cancer Research National Cancer Institute National Institutes of Health Bethesda Maryland USA
  14. 14Department of Otolaryngology‐Head and Neck Surgery Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA
  15. 15Department of Otolaryngology University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA
  16. 16Department of Otolaryngology‐Head and Neck Surgery University of California Los Angeles Los Angeles California USA
  17. 17Department of Otolaryngology‐Head and Neck Surgery University of Toronto Toronto Ontario Canada
Read full textDOICite

Abstract

Background: Survival for patients with sinonasal cancers has improved over the past decades, but there are no dedicated survivorship guidelines for this cohort.

Objective: To understand experts’ priorities and perspectives on key survivorship tenets (surveillance, second tumor screening, toxicity, and symptom management).

Method: A modified Delphi method was used for developing consensus. A preliminary list of statements was generated from literature review and rated for importance by otolaryngology experts from 15 high‐volume North American centers. Statements were rated on a Likert scale and results were discussed. Two Delphi rounds were performed to determine consensus.

Results: Consensus was reached for 30 statements. These include the role of endoscopy, imaging, frequency of surveillance stratified by histology and grade, and time following treatment completion. The group reached consensus on the importance of long‐term follow‐up for symptom and toxicity management, survivorship program enrollment, and recognizing quality of life related issues, including pituitary hormone abnormalities, neurocognition, mental health disorders, sinonasal dysfunction, vision, hearing, dental health, speech and swallowing, and neck morbidity.

Conclusion: The group reached consensus on key aspects of surveillance, toxicity and symptom management, and the importance of long‐term follow‐up and enrollment in survivorship programs. Several areas require further research, including the role of second primary tumor screening.

Related

  1. AI‐Powered TAT‐Net Hyperspectral Imaging for Rapid and Accurate Differentiation of Sinonasal Inverted Papilloma and Malignancy
    Hao‐Miao Zhao, Jia‐Chang Kong, Yun‐Ze Li +2
    World Journal of Otorhinolaryngology-Head and Neck SurgeryPeer-reviewedCC BYFull textSurgery & anaesthesiaDOAJ
  2. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe
    I. Vaz-Luis, M. Masiero, G. Cavaletti +25
    Annals of OncologyPeer-reviewedLicence not stated207 citedOncologyHAL
  3. Application of chimeric flaps for complex orbitomaxillary reconstruction in sinonasal malignancy
    Karnav Panchal, Kapila Manikantan, Saugata Samadder +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefDOAJEurope PMC
  4. International expert consensus on managing elective hernia repair in patients with Crohn’s disease using the Delphi method
    BJS openPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  5. Development of consensus-based standards for a National Clinical Audit of Perioperative Care: protocol for a modified Delphi consensus study.
    Malcolm A West, Thomas Parkington, John Moore +8
    BMJ openPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{sewastjanowsilva2026north,
  title = {{North American Delphi Consensus Study on Sinonasal Malignancy Survivorship Care}},
  author = {Matheus Sewastjanow‐Silva and Samagra Jain and Rita Snyder and Erin L. McKean and Ralph Abi Hachem and Nithin D. Adappa and J. Ken Byrd and Ricardo L. Carrau and Marc A. Cohen and Ivan H. El‐Sayed and Mathew N. Geltzeiler and Ehab Y. Hanna and Edward C. Kuan and Nyall R. London and Zoukaa B. Sargi and Carl H. Snyderman and Marilene B. Wang and Ian J. Witterick and Shirley Y. Su},
  journal = {International Forum of Allergy \& Rhinology},
  year = {2026},
  month = jul,
  doi = {10.1002/alr.70214},
  url = {https://doi.org/10.1002/alr.70214},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - North American Delphi Consensus Study on Sinonasal Malignancy Survivorship Care
AU  - Matheus Sewastjanow‐Silva
AU  - Samagra Jain
AU  - Rita Snyder
AU  - Erin L. McKean
AU  - Ralph Abi Hachem
AU  - Nithin D. Adappa
AU  - J. Ken Byrd
AU  - Ricardo L. Carrau
AU  - Marc A. Cohen
AU  - Ivan H. El‐Sayed
AU  - Mathew N. Geltzeiler
AU  - Ehab Y. Hanna
AU  - Edward C. Kuan
AU  - Nyall R. London
AU  - Zoukaa B. Sargi
AU  - Carl H. Snyderman
AU  - Marilene B. Wang
AU  - Ian J. Witterick
AU  - Shirley Y. Su
PY  - 2026
DA  - 2026/07/02
JO  - International Forum of Allergy & Rhinology
DO  - 10.1002/alr.70214
UR  - https://doi.org/10.1002/alr.70214
AB  - Background: Survival for patients with sinonasal cancers has improved over the past decades, but there are no dedicated survivorship guidelines for this cohort.  Objective: To understand experts’ priorities and perspectives on key survivorship tenets (surveillance, second tumor screening, toxicity, and symptom management).  Method: A modified Delphi method was used for developing consensus. A preliminary list of statements was generated from literature review and rated for importance by otolaryngology experts from 15 high‐volume North American centers. Statements were rated on a Likert scale and results were discussed. Two Delphi rounds were performed to determine consensus.  Results: Consensus was reached for 30 statements. These include the role of endoscopy, imaging, frequency of surveillance stratified by histology and grade, and time following treatment completion. The group reached consensus on the importance of long‐term follow‐up for symptom and toxicity management, survivorship program enrollment, and recognizing quality of life related issues, including pituitary hormone abnormalities, neurocognition, mental health disorders, sinonasal dysfunction, vision, hearing, dental health, speech and swallowing, and neck morbidity.  Conclusion: The group reached consensus on key aspects of surveillance, toxicity and symptom management, and the importance of long‐term follow‐up and enrollment in survivorship programs. Several areas require further research, including the role of second primary tumor screening.
SN  - 2042-6976
SN  - 2042-6984
ER  -